Anemia is often associated disease in patients with chronic heart failure, which reduces exercise tolerance, quality of life and worsens the prognosis in the patients. The recommendations of the leading associations of cardiology include the correction of iron deficiency and anemia in the context of the treatment of patients with chronic heart failure. Such influence and modern recommendations determine the relevance of knowledge of the prevalence and pathogenesis of anemia and iron-deficiency conditions in chronic heart failure. The purpose of the study was to review the literature illustrating current data about prevalence and pathogenesis of anemia and iron deficiency in patients with chronic heart failure. Materials and methods. This work presents review of literature about prevalence and pathogenesis of anemia and iron deficiency in patients with chronic heart failure, based on a search of English-language articles in the PubMed database for the last 20 years, by keywords – anemia, iron deficiency, chronic heart failure, pathogenesis, prevalence. Results and discussion. The frequency of anemia that patients with chronic heart failure ranges have are from 4% to 30-70% of cases, according to several studies. Such a variety of data is associated with different degrees of severity of heart failure in different studies, but they unanimously confirm the information about the significant prevalence of this condition in the studied population cohort. Iron deficiency is an important comorbid condition that patients with heart failure have and is observed in an average of 30-50% of cases, according to some data, the frequency reaches a maximum of 70-83%. Iron deficiency is the most common cause of anemia, but it is particularly interesting that approximately 46% of patients with iron deficiency do not have anemia. The following 6 factors that can be the cause of anemia individually or in combination that patients with chronic heart failure have, have been identified: iron deficiency, inflammation, erythropoietin level, medications, hemodilution, medullary dysfunction. The causes of absolute iron deficiency are anorexia, cachexia, malabsorption of iron due to intestinal edema and hepcidin-induced suppression of iron transporters, such as ferroportin, functional – chronic inflammatory state, which leads to an increase in the level of pro-inflammatory cytokines, such as interleukin-1, interleukin-6, interleukin-18, tumor necrosis factor-, which, in turn, induces the synthesis of hepcidin and, accordingly, decreases the expression of ferroportin with a decrease in the transition of iron into the state of circulation and stimulation of sequestration in macrophages of the reticuloendothelial system. Conclusion. Better understanding of the pathogenesis of these conditions that patients with chronic heart failure have, will allow the development of new methods of treatment

Keywords: anemia, iron deficiency, chronic heart failure, pathogenesis, prevalence

Full text: PDF (Ukr) 0P

1. Paolillo S, Scardovi AB, Campodonico, J. Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation. Eur J Prev Cardiol. 2020 Dec;27(2_suppl):27-34. PMID: 33238738. PMCID: PMC7691628. https://doi.org/10.1177/2047487320960288
2. Berry C, Poppe KK, Gamble GD, Earle NJ, Ezekowitz JA, Squire IB, McMurray JJV, et al. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis. QJM. 2016 Jun;109(6):377-382. PMID: 25979270 . https://doi.org/10.1093/qjmed/hcv087
3. Díez-López C, Lupón J, de Antonio M, Zamora E, Domingo M, Santesmases J, et al. Hemoglobin Kinetics and Long-term Prognosis in Heart Failure. Rev Esp Cardiol (Engl Ed). 2016 Sep;69(9):820-6. PMID: 27318441. https://doi.org/10.1016/j.rec.2016.02.028
4. Abebe TB, Gebreyohannes EA, Bhagavathula AS, Tefera YG, Abegaz TM. Anemia in severe heart failure patients: Does it predict prognosis? BMC Cardiovasc Disord. 2017 Sep 16;17(1):248. PMID: 28915848. PMCID: PMC5603085. https://doi.org/10.1186/s12872-017-0680-5
5. Cattadori G, Agostoni P, Corrà U, Sinagra G, Veglia F, Salvioni E, et al. Heart failure and anemia: Effects on prognostic variables. Eur J Intern Med. 2017 Jan;37:56-63. PMID: 27692931. https://doi.org/10.1016/j.ejim.2016.09.011
6. Kajimoto K, Minami Y, Sato N, Otsubo S, Kasanuki H; Investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) Registry. Gender Differences in Anemia and Survival in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction. Am J Cardiol. 2017 Aug 1;120(3):435-442. PMID: 28583679. https://doi.org/10.1016/j.amjcard.2017.04.043
7. Migone de Amicis M, Chivite D, Corbella X, Cappellini MD, Formiga F. Anemia is a mortality prognostic factor in patients initially hospitalized for acute heart failure. Intern Emerg Med. 2017 Sep;12(6):749-756. PMID: 28233161. https://doi.org/10.1007/s11739-017-1637-5
8. Tymińska A, Kapłon-Cieślicka A, Ozierański K, Peller M, Balsam P, Marchel M, et al. Anemia at Hospital Admission and Its Relation to Outcomes in Patients With Heart Failure (from the Polish Cohort of 2 European Society of Cardiology Heart Failure Registries). Am J Cardiol. 2017 Jun 15;119(12):2021-2029. PMID: 28434647. https://doi.org/10.1016/j.amjcard.2017.03.035
9. Dvornik Š, Zaninović Jurjević T, Jurjević N, Lekić A, Zaputović L. Prognostic factors for in-hospital mortality of patients hospitalized for acutely decompensated heart failure. Acta Clin Belg. 2018 Jun;73(3):199-206. PMID: 29207933. https://doi.org/10.1080/17843286.2017.1410599
10. van der Wal HH, Comin-Colet J, Klip IT, Enjuanes C, Grote Beverborg N, Voors AA, et al. Vitamin B12 and folate deficiency in chronic heart failure. Heart. 2015 Feb;101(4):302-10. PMID: 25324534. https://doi.org/10.1136/heartjnl-2014-306022
11. Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clark AL. Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J. 2004 May;147(5):924-30. PMID: 15131553. https://doi.org/10.1016/j.ahj.2003.11.007
12. van der Wal HH, Comin-Colet J, Klip IT, Enjuanes C, Grote Beverborg N, Voors AA, et al. Vitamin B12 and folate deficiency in chronic heart failure. Heart. 2015 Feb;101(4):302-10. PMID: 25324534. https://doi.org/10.1136/heartjnl-2014-306022
13. Malfatto G, Frisinghelli A, Ambrosetti M, La Rovere MT, Motta I, Passaretti B, et al. Iron deficiency from the standpoint of cardiac rehabilitation: Novel therapeutic opportunities. Monaldi Arch Chest Dis. 2019 Sep 20;89(3). PMID: 31850693. https://doi.org/10.4081/monaldi.2019.1118
14. Agostoni P, Salvioni E, Debenedetti C, Vignati C, Cattadori G, Contini M, et al. Relationship of resting hemoglobin concentration to peak oxygen uptake in heart failure patients. Am J Hematol. 2010 Jun;85(6):414-7. PMID: 20513118. https://doi.org/10.1002/ajh.21698
15. Agostoni P, Corrà U, Cattadori G, Veglia F, La Gioia R, Scardovi AB, et al. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. Int J Cardiol. 2013 Sep 10;167(6):2710-8. PMID: 22795401. https://doi.org/10.1016/j.ijcard.2012.06.113
16. von Haehling S, Jankowska EA, van Veldhuisen DJ, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Nat Rev Cardiol. 2015 Nov;12(11):659-69. PMID: 26194551. https://doi.org/10.1038/nrcardio.2015.109
17. van Veldhuisen DJ, Ponikowski P, van der Meer P, Metra M, Böhm M, Doletsky A, et al. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients with Chronic Heart Failure and Iron Deficiency. Circulation. 2017 Oct 10;136(15):1374-1383. PMID: 28701470. PMCID: PMC5642327. https://doi.org/10.1161/CIRCULATIONAHA.117.027497
18. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, et al. Etiology of Anemia in Patients With Advanced Heart Failure J Am Coll Cardiol. 2006 Dec 19;48(12):2485-9. PMID: 17174186. https://doi.org/10.1016/j.jacc.2006.08.034
19. Rocha BML, Cunha GJL, Menezes Falcão LF. The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach. J Am Coll Cardiol. 2018 Feb 20;71(7):782-793. PMID: 29447741. https://doi.org/10.1016/j.jacc.2017.12.027
20. Nikolaou M, Chrysohoou C, Georgilas TA, Giamouzis G, Giannakoulas G, Karavidas A, et al. Management of iron deficiency in chronic heart failure: Practical considerations for clinical use and future directions. Eur J Intern Med. 2019 Jul;65:17-25. PMID: 31109847. https://doi.org/10.1016/j.ejim.2019.05.011
21. Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol. 2013 Jul;133(7):1752-9. PMID: 23334343 . https://doi.org/10.1038/jid.2013.19
22. Gonzalez-Costello J, Cainzos-Achirica M, Lupón J, Farré N, Moliner-Borja P, Enjuanes C, et al. Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence. Eur J Intern Med. 2020 Oct;80:91-98. PMID: 32439287. https://doi.org/10.1016/j.ejim.2020.04.031
23. McDonagh T, Damy T, Doehner W, Lam CSP, Sindone A, van der Meer P, et al. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail. 2018 Dec;20(12):1664-1672. PMID: 30311713. PMCID: PMC6607482. https://doi.org/10.1002/ejhf.1305
24. Martin-Malo A, Borchard G, Flühmann B, Mori C, Silverberg D, Jankowska EA. Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patientsю ESC Heart Fail. 2019 Apr;6(2):241-253. PMID: 30694615. PMCID: PMC6437426. https://doi.org/10.1002/ehf2.12400
25. Zhang J, Hu S, Jiang Y, Zhou Y.Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: A systematic review and meta-analysis based on 15 randomised controlled trials. Postgrad Med J. 2020 Dec;96(1142):766-776. PMID: 32843482. https://doi.org/10.1136/postgradmedj-2019-137342
26. Sîrbu O, Floria M, Dascalita P, Stoica A, Adascalitei P, Sorodoc V, et al. Anemia in heart failure- from guidelines to controversies and challenges. Anatol J Cardiol. 2018 Jul;20(1):52-59. PMID: 29952364. PMCID: PMC6237795. https://doi.org/10.14744/AnatolJCardiol.2018.08634
27. Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: Diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013 Mar;34(11):816-29. PMID: 23100285. PMCID: PMC3596759. https://doi.org/10.1093/eurheartj/ehs224
28. Gunawardena S, Dunlap ME. Anemia and Iron deficiency in heart failure. Curr Heart Fail Rep. 2012 Dec;9(4):319-27. PMID: 22940847. https://doi.org/10.1007/s11897-012-0112-x
29. Silverberg DS, Wexler D, Schwartz D. Is correction of iron deficiency a new addition to the treatment of the heart failure? Int J Mol Sci. 2015;16(6):14056-14074. PMID: 26096008. PMCID: PMC4490538. https://doi.org/10.3390/ijms160614056
30. Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J. 2005 Nov;26(21):2232-7. PMID: 15987710. https://doi.org/10.1093/eurheartj/ehi388
31. Kiliçgedik A, Dündar C, Tigen MK. Kalp yetersizliǧinde anemi. Anadolu Kardiyoloji Dergisi. 2012;12(1):65-70. PMID: 22214745. https://doi.org/10.5152/akd.2012.011
32. Vasu S, Kelly P, Lawson WE. Anemia in heart failure - A concise review. Clin Cardiol. 2005;28(10):454-458. PMID: 16274092. PMCID: PMC6653873. https://doi.org/10.1002/clc.4960281003
33. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003 Jan 21;107(2):226-9. PMID: 12538419. https://doi.org/10.1161/01.CIR.0000052623.16194.80
34. Drakos SG, Anastasiou-Nana MI, Malliaras KG, Nanas JN. Anemia in chronic heart failure. Congest Heart Fail. 2009 Mar-Apr;15(2):87-92. PMID: 19379455. https://doi.org/10.1111/j.1751-7133.2009.00049.x
35. Anand IS. Heart failure and anemia: Mechanisms and pathophysiology. Heart Fail Rev. 2008 Dec;13(4):379-86. PMID: 18236152. https://doi.org/10.1007/s10741-008-9088-8
36. Lill R, Hoffmann B, Molik S, Pierik AJ, Rietzschel N, Stehling O, et al. The role of mitochondria in cellular iron-sulfur protein biogenesis and iron metabolism. Biochim Biophys Acta. 2012 Sep;1823(9):1491-508. PMID: 22609301. https://doi.org/10.1016/j.bbamcr.2012.05.009
37. Koskenkorva-Frank TS, Weiss G, Koppenol WH, Burckhardt S. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med. 2013 Dec;65:1174-1194. PMID: 24036104. https://doi.org/10.1016/j.freeradbiomed.2013.09.001
38. Musallam KM, Taher AT. Iron deficiency beyond erythropoiesis: should we be concerned? Curr Med Res Opin. 2018;34(1):81-93. PMID: 29050512. https://doi.org/10.1080/03007995.2017.1394833
39. Magrì D, De Martino F, Moscucci F, Agostoni P, Sciomer S. Anemia and Iron Deficiency in Heart Failure: Clinical and Prognostic Role. Heart Fail Clin. 2019 Jul;15(3):359-369. PMID: 31079694. https://doi.org/10.1016/j.hfc.2019.02.005
40. Hershko C. Mechanism of iron toxicity. Food Nutrit Bull. 2007;28(4):500-509. PMID: 18297888. https://doi.org/10.1177/15648265070284s403
41. Antunes SA, Canziani MEF. Hepcidin: an important iron metabolism regulator in chronic kidney disease. J Brasil Nefrol.  2016;38(3):351-355. https://doi.org/10.5935/0101-2800.20160053
42. Dunn LL, Rahmanto YS, Richardson DR. Iron uptake and metabolism in the new millennium. Trends Cell Biol. 2007;17(2):93-100. PMID: 17194590. https://doi.org/10.1016/j.tcb.2006.12.003
43. De Domenico I, McVey Ward D, Kaplan J. Regulation of iron acquisition and storage: Consequences for iron-linked disorders. Nat Rev Mol Cell Biol. 2008;9(1):72-81. PMID: 17987043. https://doi.org/10.1038/nrm2295
44. Gkouvatsos K, Papanikolaou G, Pantopoulos K. Regulation of iron transport and the role of transferrin. Biochim Biophys Acta - General Subjects. 2012;1820(3):188-202. PMID: 22085723. https://doi.org/10.1016/j.bbagen.2011.10.013
45. Anand IS, Gupta P. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies. Circulation. 2018;138(1):80-98. PMID: 29967232. https://doi.org/10.1161/CIRCULATIONAHA.118.030099
46. Cohen-Solal A, Leclercq C, Mebazaa A, De Groote P, Damy T, Isnard R, et al. 'Diagnosis and treatment of iron deficiency in patients with heart failure: Expert position paper from French cardiologists. Arch Cardiovasc Dis. 2014;107(10):563-571. PMID: 25239645. https://doi.org/10.1016/j.acvd.2014.07.049
47. Mordi IR, Tee A, Lang CC. Iron Therapy in Heart Failure: Ready for Primetime? Cardiac Failure Rev. 2018;4(1):1. https://doi.org/10.15420/cfr.2018:6:2
48. Cunha GJL, Rocha BML, enezes Falcão L. Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions. Eur J Int Med. 2018;52:1-7. PMID: 29680173. https://doi.org/10.1016/j.ejim.2018.04.013
49. Alexandrakis MG, Tsirakis G. Anemia in Heart Failure Patients. ISRN Hematol. 2012;2012:1-9. PMID: 22536520. PMCID: PMC3319993. https://doi.org/10.5402/2012/246915
50. Anand I. Iron deficiency in heart failure. Cardiol (Switzerland). 2014;128(4):317-319. PMID: 24923867. https://doi.org/10.1159/000361040